Skip to content
value.today

SenesTech, Inc.

🇺🇸 Phoenix, Arizona, USABiotechnologyFounded 2015

SenesTech, Inc. is listed today as SenesTech, Inc.: market value, financials and filings are on its company page.

Funding rounds

0 counted as startup funding, 4 other private sales on record. Open the number of investors for the round's details.

Funding rounds of SenesTech, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2023$2 MPrivate placement after listingUnder $2 million

SenesTech, Inc.: Private sale, Apr 2023

Investors in this round

4 investors had bought by the notice of Apr 26, 2023: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Common Stock purchase and Series C Warrant shares in concurrent private placement.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$112,500
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Joel L. Fruendt · Executive Officer, Director · Chief Executive Officer
  • Nicole L. Williams · Executive Officer, Director · Chief Revenue Officer
  • Thomas C. Chesterman · Executive Officer · Executive Vice President, Chief Financial Officer, Treasurer and Secretary
  • Delphine Francois Chiavarini · Director
  • Jake K. Leach · Director
  • Jamie K. Bechtel, JD, Ph.D. · Director
  • Marc C. Dumont · Director
  • Matthew K. Szot · Director
  • Phil L. Grandinetti, III · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • H.C. Wainwright & Co., LLC (CRD 375) · New York, New YorkSold in DE

Remarks in the notice

  • On fees: “In addition to the sales commissions noted above, the placement agent also received placement agent warrants to purchase up to an aggregate of 64,286 shares of Issuer's common stock at an exercise price of $2.1875 per share.”

Signed by Thomas C. Chesterman, Executive VP, CFO, Treasurer & Secretary. Source: SEC Form D, newest notice filed Apr 26, 2023. Read the notice at the SEC.

equity, optionsSEC
Jan 2021$10 MPrivate placement after listing$10 to $50 million

SenesTech, Inc.: Private sale, Jan 2021

Investors in this round

19 investors had bought by the notice of Feb 10, 2021: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$850,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kenneth Siegel · Executive Officer, Director · Chief Executive Officer and Director
  • Kim C Wolin · Executive Officer · Executive Vice President, Operations and Secretary
  • Steven C Krause, Ph.D. · Executive Officer · Executive Vice President, Sales and Marketing
  • Thomas C Chesterman · Executive Officer · Chief Financial Officer
  • Delphine C Chiavarini · Director
  • Jake C Leach · Director
  • Jamie C Bechtel, JD, Ph.D. · Director
  • K.C. C Kavanagh · Director
  • Marc C Dumont · Director
  • Matthew C Szot · Director
  • Phil C Grandinetti, III · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • H.C. Wainwright & Co. (CRD 375) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “In connection with the private placement, the Company paid H.C. Wainwright & Co., as placement agent, a fee of $850,000.33, which includes a cash fee of $750,000.29, a management fee of $100,000.04, as well as expense reimbursements totaling $75,000.”
  • On the amounts: “This amount does not include warrants issued to the placement agent.”

Signed by Thomas C. Chesterman, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 10, 2021. Read the notice at the SEC.

equity, optionsSEC
Oct 2020$3 MPrivate placement after listing$2 to $10 million

SenesTech, Inc.: Private sale, Oct 2020

Investors in this round

5 investors had bought by the notice of Nov 10, 2020: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$220,025
Finders' fees
$29,337
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kenneth Siegel · Executive Officer, Director · Chief Executive Officer
  • Thomas C Chesterman · Executive Officer · Chief Financial Officer
  • Delphine Francois Chiavarini · Director
  • Jamie C Bechtel, JD, Ph.D. · Director
  • Julie Francois Williams, MD · Director
  • Marc Francois Dumont · Director
  • Matthew Francois Szot · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • H.C. Wainwright & Co. (CRD 375) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “In connection with the warrant exchange transaction, the Company paid H.C. Wainwright & Co., as placement agent, a cash fee of $220,025.48 and a management fee of $29,336.73.”
  • On the use of proceeds: “Assist with execution of business strategy and other general corporate purposes.”

Signed by Thomas C. Chesterman, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 10, 2020. Read the notice at the SEC.

equity, optionsSEC
Jan 2020$2 MPrivate placement after listingUnder $2 million

SenesTech, Inc.: Private sale, Jan 2020

Investors in this round

42 investors had bought by the notice of Feb 12, 2020: 42 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$14,200
Finders' fees
$106,500
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kenneth Siegel · Executive Officer, Director · Chief Executive Officer and Director
  • Thomas C Chesterman · Executive Officer · Chief Financial Officer
  • Delphine Francois Chiavarini · Director
  • Jamie C Bechtel, JD, Ph.D. · Director
  • Julie Francois Williams, MD · Director
  • Marc Francois Dumont · Director
  • Matthew Francois Szot · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • H.C. Wainwright & Co. (CRD 375) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “In connection with the registered direct offering concurrent with the private placement, the Company paid H.C. Wainwright & Co., the placement agent, a $106,500 cash fee and a $14,200 management fee in addition to other expenses.”
  • On the amounts: “The amount sold reflects the purchase amount of the warrants issued to investors and the warrants issued to H.C. Wainwright & Co., the placement agent of the private placement.”

Signed by Thomas C. Chesterman, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 12, 2020. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • SenesTech, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2023).

    SEC Form D · Apr 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2023

That is all the official record says: SenesTech, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of SenesTech, Inc. are on record.

Investors#

No investor of SenesTech, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.

Largest shareholders today

Institutions holding SenesTech, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by SenesTech, Inc.
NameRoleNamed in
Joel L. FruendtChief Executive OfficerApr 2023
Nicole L. WilliamsChief Revenue OfficerApr 2023
Thomas C. ChestermanExecutive Vice President, Chief Financial Officer, Treasurer and SecretaryApr 2023
Kenneth SiegelChief Executive Officer and DirectorFeb 2021
Kim C WolinExecutive Vice President, Operations and SecretaryFeb 2021
Steven C Krause, Ph.D.Executive Vice President, Sales and MarketingFeb 2021
Thomas C ChestermanChief Financial OfficerFeb 2021
Delphine Francois ChiavariniDirectorApr 2023
Jake K. LeachDirectorApr 2023
Jamie K. Bechtel, JD, Ph.D.DirectorApr 2023
Joel L. FruendtChief Executive OfficerApr 2023
Marc C. DumontDirectorApr 2023
Matthew K. SzotDirectorApr 2023
Nicole L. WilliamsChief Revenue OfficerApr 2023
Phil L. Grandinetti, IIIDirectorApr 2023
Delphine C ChiavariniDirectorFeb 2021
Jake C LeachDirectorFeb 2021
Jamie C Bechtel, JD, Ph.D.DirectorFeb 2021
K.C. C KavanaghDirectorFeb 2021
Kenneth SiegelChief Executive Officer and DirectorFeb 2021
Marc C DumontDirectorFeb 2021
Matthew C SzotDirectorFeb 2021
Phil C Grandinetti, IIIDirectorFeb 2021
Julie Francois Williams, MDDirectorNov 2020
Marc Francois DumontDirectorNov 2020
Matthew Francois SzotDirectorNov 2020

Went public since 2016. Its SEC number is that of a company listed on a stock exchange.